Renal Medical Devices and Services Market - Growth, Trends and Forecast (2020 - 2025)

The market is segmented by Product, Application (Kidney Failure, Chronic Kidney Disease, End-stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, Anemia), and Geography.

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

6.4 %

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Kidney disease affects a large amount of global popualtion and has increased in the recent decades. It occurs when your kidneys become damaged and can’t perform their function. Damage may be caused by diabetes, high blood pressure, and various other chronic (long-term) conditions. Kidney disease can lead to other health problems, including weak bones, nerve damage, and malnutrition. Moreover, geriatric population is more prone to kidney disorders. As the geriatric population is growing, the prevalence kidney disorders are also expected to increase.

However, reimbursement issues have been dissuading many manufacturers from entering the market. Also, lack of awareness regarding the presence of such renal disorders treatment in developing and under-developed countries is hindering the market growth.

Scope of the Report

Renal medical devices and services are used to treat or alleviate renal disorders. In the report, a detailed analysis of the renal medical devices and services market is provided. The market is evaluated by collating revenues generated across segments, categorized by Product, Application, and Geography.

By Product
Dialysis Equipment
Renal Denervation Devices
Wearable Artificial Kidney Device
Distal Embolic Protection Devices
By Application
Kidney Failure
Chronic Kidney Disease
End-stage Kidney Disease
Renal Kidney Stone Disease
Hypertension
Diabetes
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Renal Kidney Stone Disease is Expected to Register a High CAGR

A kidney stone is a hard, crystalline mineral material formed within the kidney or urinary tract. Kidney stones are a common cause of blood in the urine (hematuria) and often severe pain in the abdomen, flank, or groin. Moreover,  as the kidney stones prevalence incidence with age, as per Justin B. Ziemba et al, published in Investigative and Clinical Urology, 2017. The study has reported that the prevalence in 20 to 29-year-old adults is 3.1% for both men and women, which then increases and peaks in 60 to 69-year-old adults at 19.1% in men and 9.4% in women. 

A United Nations report, World Population Ageing, published in 2017 states that the global population is aging, especially in developed countries. Hence, as the geriatric population increase, the incidence of kidney stones is also expected to increase. This increases the overall demand for medical devices for kidney stones removal procedures, which will help the market to grow.

To understand key trends, Download Sample Report

North America is Expected to Dominate the Market

The North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

To understand geography trends, Download Sample Report.

Competitive Landscape

Majority of the renal medical devices and services are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidences of Kidney Diseases

      2. 4.2.2 Rise in Prevalence of Diabetes and High Blood Pressure Conditions

      3. 4.2.3 Growing Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 Reimbursement Issues

      2. 4.3.2 Lack of Awareness in Developing and Under-Developed Regions

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Dialysis Equipment

      2. 5.1.2 Renal Denervation Devices

      3. 5.1.3 Wearable Artificial Kidney Device

      4. 5.1.4 Distal Embolic Protection Devices

    2. 5.2 By Application

      1. 5.2.1 Kidney Failure

      2. 5.2.2 Chronic Kidney Disease

      3. 5.2.3 End-stage Kidney Disease

      4. 5.2.4 Renal Kidney Stone Disease

      5. 5.2.5 Hypertension

      6. 5.2.6 Diabetes

      7. 5.2.7 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 B Braun Melsungen AG

      3. 6.1.3 Baxter International Inc

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Boston Scientific Corporation

      6. 6.1.6 DaVita Healthcare Partners, Inc

      7. 6.1.7 Fresenius Medical

      8. 6.1.8 Infomed SA

      9. 6.1.9 Medtronic

      10. 6.1.10 Nipro Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Related Reports